CVM

CEL-SCI Corporation

There isn't enough reported data to score CVM yet.

CVM Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Unavailable

CVM's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.

CVM PE Valuation

CVM has no meaningful PE right now: it lost money over the past year.

CVM Forward outlook

There aren't enough analyst estimates for CVM to show an outlook.

CVM Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $1.19 on Nov 12.

There is not enough scenario data to assess CVM's risk to reward.

CVM Earnings Per Share

Q3 2024: $-15.30Q4 2024: $-14.58Q1 2025: $-12.97Q2 2025: $-10.66
Q3 2024: $-15.30Q4 2024: $-14.58Q1 2025: $-12.97Q2 2025: $-10.66
QuarterTTM EPSYoY
Q2 2023-$22.61+$2.89
Q1 2023-$24.20+$1.90
Q4 2022-$25.50+$2.10
Q3 2022-$26.10+$1.80
Q2 2022-$25.50+$0.90
Q1 2022-$26.10+$0.90
Q4 2021-$27.60-$1.50
Q3 2021-$27.90-$3.30

CVM is still losing money, but far less than before: $10.66 per share over the past year, against $27.90 at its worst in late 2021.

CVM Quarterly Revenue

Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --
Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --

CVM Free Cash Flow

Q3 2023: โˆ’$5MQ4 2023: โˆ’$5MQ1 2024: โˆ’$5MQ2 2024: โˆ’$5MQ3 2024: โˆ’$5MQ4 2024: โˆ’$4MQ1 2025: โˆ’$4MQ2 2025: โˆ’$4MQ3 2025: โˆ’$5MQ4 2025: โˆ’$4MQ1 2026: โˆ’$4MQ2 2026: โˆ’$4M
Q3 2023: โˆ’$5MQ4 2023: โˆ’$5MQ1 2024: โˆ’$5MQ2 2024: โˆ’$5MQ3 2024: โˆ’$5MQ4 2024: โˆ’$4MQ1 2025: โˆ’$4MQ2 2025: โˆ’$4MQ3 2025: โˆ’$5MQ4 2025: โˆ’$4MQ1 2026: โˆ’$4MQ2 2026: โˆ’$4M
QuarterFree cash flowYoY
Q2 2026-$4M-$91.6K
Q1 2026-$4M+$347.2K
Q4 2025-$4M+$150.8K
Q3 2025-$4.7M+$160.8K
Q2 2025-$3.9M+$662.7K
Q1 2025-$4.4M+$158.1K
Q4 2024-$4.2M+$766.7K
Q3 2024-$4.8M+$208.3K

CVM has burned cash in almost every quarter: โˆ’$17M over the past year, against โˆ’$17M the year before.

CVM Total Shares

Q3 2023: 2MQ4 2023: 2MQ1 2024: 2MQ2 2024: 2MQ4 2024: 2MQ1 2025: 3MQ2 2025: 4MQ4 2025: 8MQ1 2026: 8MQ2 2026: 12M
Q3 2023: 2MQ4 2023: 2MQ1 2024: 2MQ2 2024: 2MQ4 2024: 2MQ1 2025: 3MQ2 2025: 4MQ4 2025: 8MQ1 2026: 8MQ2 2026: 12M
PeriodChange %Net change
Quarterly+49%+4M shares
1 year+330%+9.3M shares
3 years+718%+10.6M shares
5 years+838%+10.8M shares
Available history+1066%+11.1M shares

CVM has 12M diluted shares, up 330% from a year ago.

CVM Net Leverage

CVM's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

CVM Weekly Momentum

MetricValueStatus
RSI38.3Neutral
Stochastic10.7Oversold

CVM's weekly RSI is 38 (neutral) and its Stochastic is 11 (oversold).

CVM PE vs Healthcare Sector

CVM has no meaningful PE right now: it lost money over the past year.

CVM Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.6729% below
20 week MA$1.5222% below
50 week MA$2.8458% below
100 week MA$6.1881% below
200 week MA$35.497% below

CVM is in a downtrend: it's below all five of its weekly moving averages, and 97% below its 200-week average.

CVM Yearly ROI

YearStart priceEnd priceROI
2020$309.0$461.1+49%
2021$461.1$301.2-35%
2022$301.2$82.5-73%
2023$82.5$97.8+19%
2024$97.8$21.6-78%
2025$21.6$4.71-78%
2026 YTD$4.71$1.19-75%

CVM has finished lower in four of the last six years. It's down 75% so far in 2026.

Give your agent the market.

Get API key